Author

Melissa Campanelli

Observed names: M Campanelli, M. Campanelli

Institution: Azienda Sanitaria Unità Locale di Reggio Emilia

Observed institutions: Policlinico Umberto I, Azienda Sanitaria Unità Locale di Reggio Emilia, Sapienza University of Rome

OpenAlex ID: A5111764391

Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease

2015 · F R Mauro, S Chauvie, et al. · Leukemia · 77

Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients

2016 · Massimo Gentile, Tait D. Shanafelt, et al. · Blood · 62

Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma

2017 · Francesca Romana Mauro, Piero Galieni, et al. · American Journal of Hematology · 28

Italian external and multicentric validation of the MD A nderson C ancer C enter nomogram and prognostic index for chronic lymphocytic leukaemia patients: analysis of 1502 cases

2014 · Massimo Gentile, Francesca R. Mauro, et al. · British Journal of Haematology · 26

Clinical relevance of hypogammaglobulinemia, clinical and biologic variables on the infection risk and outcome of patients with stage A chronic lymphocytic leukemia

2017 · Francesca R. Mauro, Fortunato Morabito, et al. · Leukemia Research · 23

“Zeus” a new oral anticoagulant therapy dosing algorithm : A cohort study

2011 · A. Cafolla, R. Melizzi, et al. · Thrombosis Research · 21

Management of elderly and unfit patients with chronic lymphocytic leukemia

2016 · Francesca R. Mauro, Adriano Salaroli, et al. · Expert Review of Hematology · 8

Oral anticoagulant therapy in I talian patients 80 yr of age or older with atrial fibrillation: a pilot study of low vs. standard PT / INR targets

2012 · Arturo Cafolla, Melissa Campanelli, et al. · European Journal Of Haematology · 8

Clinical results according to age in patients with chronic myeloid leukemia receiving imatinib frontline: The younger, the later, the worse?

2018 · Roberto Latagliata, Massimo Breccia, et al. · European Journal Of Haematology · 5

Pulmonary Infections in Patients with Myelodysplastic Syndromes Receiving Azacytidine Treatment

2016 · Roberto Latagliata, Pasquale Niscola, et al. · Blood · 3

Effectiveness and Safety of Therapy with Vitamin K Antagonists in Italian Patients Aged 80 Years or Older: a Multicentre Retrospective Study Comparing the Zeus Algorithm with the PARMA Algorithm or Manual Therapy

2015 · Arturo Cafolla, Luigia Manisco, et al. · Drugs & Aging · 3

Venetoclax and Azacitidine for Relapse Prevention in NPM1-Mutated Acute Myeloid Leukemia in Molecular Failure: Results from the Ongoing Gimema AML2521 Phase 2 Trial

2024 · Chiara Sartor, Anna Candoni, et al. · Blood · 2

Incidence of Severe (≤ 10g/dl) Chronic Anemia in Elderly Patients with Newly Diagnosed Chronic Myeloid Leukemia Treated with Imatinib and Role of Erythropoietin Therapy

2016 · Laura Cesini, Ida Carmosino, et al. · Blood · 1

A pre-emptive bridge-to-transplant therapy for measurable residual disease with venetoclax and azacitidine in NPM1-mutated Acute Myeloid Leukemia: Updates from the ongoing GIMEMA AML2521 phase 2 trial

2025 · Chiara Sartor, Anna Candoni, et al. · Blood

Esophageal Motility Disorder in Gastrophageal Reflux Disease

2016 · Michele Grande, Giorgio Lisi, et al. · Cineca Institutional Research Information System (Tor Vergata University)

Works count: 15

Citation count: 267

H-index: 8

I10-index: 6